ERD

EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

01-01-2016

-

31-12-2023

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

IDERHA | Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

01-04-2023

-

31-03-2028

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

VICT3R | Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

01-09-2024

-

29-02-2028

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

VITAL | Vaccines and Infectious Diseases in the Ageing PopuLation

01-01-2019

-

31-12-2024

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

PrIMAVeRa | Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance

01-11-2021

-

31-10-2026

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

OptiMalVax | Optimizing a deployable high efficacy malaria vaccine

01-01-2017

-

31-12-2022

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

INITIATE | INnate-ImmunomeTabolIsm as Antiviral TargEt

01-05-2019

-

30-04-2023

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

EBOVAC2 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861

01-12-2014

-

31-05-2021

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure

01-06-2018

-

30-09-2024

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

EBOVAC1 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854

01-12-2014

-

30-11-2021

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

EDGE | Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology

01-05-2016

-

31-10-2020

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

iAds | Intelligent design of adenovirus vectors (iAds)

01-05-2023

-

30-04-2027

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

ReCHISVac | Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection.

01-06-2022

-

30-11-2024

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

EBOMAN | Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) – Sofia ref.: 115850

01-12-2014

-

30-11-2017

Show more information

Organisation JANSSEN VACCINES & PREVENTION BV

Projects overview

Selected filters:

EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

IDERHA | Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

VICT3R | Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research

VITAL | Vaccines and Infectious Diseases in the Ageing PopuLation

PrIMAVeRa | Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance

OptiMalVax | Optimizing a deployable high efficacy malaria vaccine

INITIATE | INnate-ImmunomeTabolIsm as Antiviral TargEt

EBOVAC2 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II - Sofia ref.: 115861

EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure

EBOVAC1 | Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen – Sofia ref.: 115854

EDGE | Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology

iAds | Intelligent design of adenovirus vectors (iAds)

ReCHISVac | Experimental vaccinology, revealing unnatural signatures of protection by repeat controlled human schistosome infection.

EBOMAN | Manufacturing and Development for Rapid Access Ebola Vaccine (EBOMAN) – Sofia ref.: 115850